Inozyme Pharma Inc.

NASDAQ: INZY · Real-Time Price · USD
4.00
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM

Inozyme Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-102.02M -71.17M -67.06M -56.62M
Depreciation & Amortization
742K 833K 744K 674K
Stock-Based Compensation
7.95M 7.04M 7.67M 7.16M
Other Working Capital
3.35M -1.7M 1.86M 760K
Other Non-Cash Items
-3.28M -4.29M -1.13M 378K
Deferred Income Tax
n/a n/a n/a 170K
Change in Working Capital
4.71M -3.08M 2.01M 85K
Operating Cash Flow
-91.91M -70.67M -57.76M -48.15M
Capital Expenditures
-62K -298K -410K -397K
Cash Acquisitions
n/a n/a 4.99K -43.19K
Purchase of Investments
-155.05M -269.33M -151.99M -121.97M
Sales Maturities Of Investments
222.11M 215.98M 147M 165.16M
Other Investing Acitivies
n/a n/a -4.99K 43.19K
Investing Cash Flow
67M -53.65M -5.4M 42.8M
Debt Repayment
n/a 40M 4.05M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
877K 322K 12.6M 609K
Financial Cash Flow
11.4M 125.97M 72.79M 609K
Net Cash Flow
-13.51M 1.63M 9.6M -4.72M
Free Cash Flow
-91.97M -70.97M -58.17M -48.55M